Genotropin

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

11 competitors in Acromegaly

#DrugCompanyPhaseTrials

1

Sandostatin

Sun Pharma

Approved

72

Lanreotide Acetate

AAlbireo, an Ipsen Company

Approved

53

Dostinex

Pfizer

Preclinical

—4

MAR002

MMarea Therapeutics

Phase 2

15

Sandostatin

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Preclinical

16

Genotropin

Pfizer

Preclinical

1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Growth Hormone Deficiency6 trials

Dose Finding Study of GX-H9 in Paeditaric Patients With Growth Hormone Deficiency

Completed·GGenexine, Inc.·Phase 2·NCT03309891·56 enrolled

Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury

Terminated·Pfizer·Phase 4·NCT00555009·10 enrolled

A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency

Unknown status·Changchun GeneScience Pharmaceutical Co., Ltd.·Phase 3·NCT06007417·162 enrolled

Show 3 more trials

A Study of Zomacton in Children With Growth Hormone Deficiency

Completed·Ferring·Phase 3·NCT00884000·165 enrolled

Safety and Efficacy Study of MOD-4023 to Treat Children With Growth Hormone Deficiency

Completed·OOPKO Health, Inc.·Phase 3·NCT03874013·44 enrolled

Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients

Completed·Hanmi Pharmaceutical Company Limited·Phase 2·NCT01822340·72 enrolled

Growth5 trials

Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD

Completed·Pfizer·Phase 3·NCT03831880·87 enrolled

Individualizing Dose of Growth Hormone to Maintain Normal Growth Velocity After Fulfilled Catch up Growth in Children

Completed·GGöteborg University·Phase 2/3·NCT02879747·99 enrolled

Hormone Treatment in Growth Hormone and Testosterone Deficient Patients

Terminated·MMax-Planck-Institute of Psychiatry·Phase 2·NCT01397500·54 enrolled

Show 2 more trials

The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients

Completed·HHvidovre University Hospital·Phase 4·NCT00119769·46 enrolled

Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood Transplant

Terminated·MMitchell Horwitz, MD·Phase 1·NCT00737113·14 enrolled

Small for gestational age3 trials

Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.

Recruiting·RRabin Medical Center·Phase 3·NCT07226089·254 enrolled

Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA)

Completed·Pfizer·Phase 4·NCT01859949·62 enrolled

Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age

Completed·Pfizer·Phase 3·NCT00174408·110 enrolled

Efficacy and Safety2 trials

Efficacy and Safety of DA-3002 in Short Children Borns SGA.

Completed·DDong-A ST Co., Ltd.·Phase 3·NCT02770157·75 enrolled

A Clinical Study to Assess the Efficacy and Safety of DA-3002

Completed·DDong-A ST Co., Ltd.·Phase 3·NCT01813630·58 enrolled

Acromegaly1 trial

Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects

Completed·UUniversity of Aarhus·N/A·NCT01723748·18 enrolled

7 more indications

Prader-Willi syndrome1 trial

Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome

Completed·LLG Life Sciences·Phase 3·NCT02204163·34 enrolled

Juvenile Idiopathic Arthritis1 trial

Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis

Completed·LLudwig-Maximilians - University of Munich·Phase 3·NCT00420251·50 enrolled

Adult Subject1 trial

A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects

Completed·Novo Nordisk·Phase 1·NCT01943084·32 enrolled

Efficacy1 trial

A Clinical Study in AGHD to Assess Safety, Tolerability and Efficacy of GX-H9

Completed·GGenexine, Inc.·Phase 2·NCT02946606·45 enrolled

Short stature1 trial

Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature

Completed·Pfizer·Phase 3·NCT00396097·316 enrolled

Brain Injury1 trial

Growth Hormone and Brain Functioning After Traumatic Brain Injury

Completed·JJoe Springer·Phase 1·NCT01699308·15 enrolled

Unspecified1 trial

A PHASE 1, OPEN-LABEL, RANDOMIZED, SINGLE-DOSE, CROSSOVER STUDY TO EVALUATE THE BIOEQUIVALENCE OF TWO DIFFERENT INJECTOR PEN DEVICES FOLLOWING SUBCUTANEOUS ADMINISTRATION OF THE SAME GENOTROPIN® (SOMATROPIN) DOSE IN HEALTHY ADULT PARTICIPANTS

Completed·Pfizer·Phase 1·NCT07542886·27 enrolled

Details

Drug Info

Related News